HIGH · 7.8

CVE-2020-26893

An issue was discovered in ClamXAV 3 before 3.1.1. A malicious actor could use a properly signed copy of ClamXAV 2 (running with an injected malicious dylib) to communicate with ClamXAV 3's helper too...

Vulnerability Description

An issue was discovered in ClamXAV 3 before 3.1.1. A malicious actor could use a properly signed copy of ClamXAV 2 (running with an injected malicious dylib) to communicate with ClamXAV 3's helper tool and perform privileged operations. This occurs because of inadequate client verification in the helper tool.

CVSS Score

7.8

HIGH

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
ClamxavClamxav>= 3.0.0, < 3.1.1

Related Weaknesses (CWE)

References

FAQ

What is CVE-2020-26893?

CVE-2020-26893 is a vulnerability with a CVSS score of 7.8 (HIGH). An issue was discovered in ClamXAV 3 before 3.1.1. A malicious actor could use a properly signed copy of ClamXAV 2 (running with an injected malicious dylib) to communicate with ClamXAV 3's helper too...

How severe is CVE-2020-26893?

CVE-2020-26893 has been rated HIGH with a CVSS base score of 7.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2020-26893?

Check the references section above for vendor advisories and patch information. Affected products include: Clamxav Clamxav.